Skip to main content

Table 1 The expression of PEG10 in cancer patients and cancer cell lines

From: PEG10 as an oncogene: expression regulatory mechanisms and role in tumor progression

Tumors Type Methods Expression References
HCC Primary HCC IHC 15/16a [9]
HCC tissues and cell lines cDNA microarray Significantly higher [16]
HCC cell lines QPCR 18/20b [17]
Primary HCC QPCR Significantly higher
HCC tissues IHC 148/218a [19]
Pancreatic carcinoma Pancreatic carcinoma tissues IHC 85/160b [20]
Breast cancer Ductal carcinoma IHC 6/11a [10]
Invasive ductal carcinomas IHC 7/22a
Breast cancer tissue (n = 161) IHC 36%a
Prostate cancer Prostate cancer tissue (n = 30) IHC 37%a [10]
Gallbladder carcinoma Gallbladder adenocarcinoma tissues IHC 52/108a [21]
Thyroid cancer 24 thyroid cancer tissues and 14 normal thyroid tissues QPCR Significantly higher (P = 0.034) [22]
OSCC OSCC tissues QPCR 83/118b [23]
Colon cancer Colon cancer tissues QPCR and WB 9/20a [24]
Enchondromas Enchondromas tissues IHC and QPCR Strongly positive expression [25]
B-CLL B-CLL PBMNCs QPCR 40/42b [26]
  1. IHC immunohistochemistry, QPCR quantitative polymerase chain reaction, OSCC oral squamous cell carcinoma, WB western blot, PBMNC peripheral blood mononuclear cell
  2. aProportion of PEG10-positive tumor tissues/cells
  3. bProportion of tumor tissues/cells occurred PEG10 upregulation compared to normal tissues/cells